Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
AbbVie
ABBV
|
+$1.41B |
| 2 |
Eli Lilly
LLY
|
+$945M |
| 3 |
Exxon Mobil
XOM
|
+$890M |
| 4 |
RTX Corp
RTX
|
+$675M |
| 5 |
Verizon
VZ
|
+$660M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$1.81B |
| 2 |
Deutsche Bank
DB
|
+$1.49B |
| 3 |
Amgen
AMGN
|
+$1.06B |
| 4 |
Charles Schwab
SCHW
|
+$1.02B |
| 5 |
Broadcom
AVGO
|
+$965M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 16.3% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Industrials | 10.89% |
| 5 | Financials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Montrose Environmental
MEG
$1.08B
| $66.6M | 0.02% |
1,972,095
-727,679
| -27% | -$24.6M |
|
302
Encompass Health
EHC
$12.6B
| $66.3M | 0.02% |
1,487,309
+684,610
| +85% | +$30.5M |
|
|
UCB
303
United Community Banks, Inc.
UCB
$3.85B
| $65.8M | 0.02% |
2,179,000
| – | – |
|
304
AvidXchange
AVDX
$2.06B
| $65.6M | 0.02% |
10,683,279
-3,155,588
| -23% | -$19.4M |
|
305
Edwards Lifesciences
EW
$44.6B
| $63.7M | 0.02% |
670,162
| – | – |
|
306
StoneCo
STNE
$4.99B
| $62.6M | 0.02% |
8,128,969
-5,133,225
| -39% | -$39.5M |
|
307
Steel Dynamics
STLD
$19.4B
| $62.4M | 0.02% |
+942,550
| New | +$62.4M |
|
308
MACOM Technology Solutions
MTSI
$9.79B
| $61.3M | 0.02% |
1,330,000
| – | – |
|
309
Playtika
PLTK
$1.35B
| $61.1M | 0.02% |
4,611,436
-3,181,345
| -41% | -$42.1M |
|
310
Fortive
FTV
$16.4B
| $59M | 0.02% |
1,085,000
| – | – |
|
311
Silicon Laboratories
SLAB
$4.41B
| $58.8M | 0.02% |
419,000
| – | – |
|
312
Ford
F
$46.5B
| $58.2M | 0.02% |
5,232,640
+22,680
| +0.4% | +$252K |
|
313
Alexandria Real Estate Equities
ARE
$14.6B
| $58.1M | 0.02% |
400,426
-1,150,365
| -74% | -$167M |
|
|
AMED
314
DELISTED
Amedisys
AMED
| $57.5M | 0.02% |
547,066
| – | – |
|
|
AZUL
315
DELISTED
Azul
AZUL
| $57.4M | 0.02% |
8,079,397
-4,952,737
| -38% | -$35.2M |
|
316
Intel
INTC
$116B
| $56.4M | 0.02% |
1,506,605
-653,754
| -30% | -$24.5M |
|
317
Kroger
KR
$44.6B
| $55.2M | 0.02% |
1,166,596
-581
| -0% | -$27.5K |
|
318
Helmerich & Payne
HP
$2.08B
| $55M | 0.02% |
1,278,249
| – | – |
|
319
Bristol-Myers Squibb
BMY
$94.3B
| $54.6M | 0.02% |
+709,449
| New | +$54.6M |
|
320
Emerson Electric
EMR
$76.3B
| $54.4M | 0.02% |
683,982
| – | – |
|
321
Dole
DOLE
$1.3B
| $54M | 0.02% |
6,388,438
-2,400,145
| -27% | -$20.3M |
|
322
Eastern Bankshares
EBC
$3.44B
| $53.5M | 0.02% |
2,896,164
| – | – |
|
323
BOK Financial
BOKF
$7B
| $52.3M | 0.02% |
692,457
-827,422
| -54% | -$62.5M |
|
|
GTM
324
ZoomInfo Technologies
GTM
$3.89B
| $51.9M | 0.02% |
1,560,417
-629,076
| -29% | -$20.9M |
|
|
AEPPZ
325
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $51.5M | 0.02% |
953,221
-600,000
| -39% | -$32.4M |
|